Skip to main content
OpenTrials

Clinical trial condition

Blood Protein Disorders

Explore clinical trials studying Blood Protein Disorders. Study availability and eligibility vary by location and protocol.

3,034 public trials 567 recruiting studies
Refine in advanced search Browse all conditions

Blood Protein Disorders trial results

Active, Not Recruiting

A Study to Assess Adverse Events and Change in Disease State of Intravenously (IV) Infused Etentamig (ABBV-383) of Adult Participants With Relapsed or Refractory Multiple Myeloma in Japan

NCT05286229

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • National Cancer Center Hospital East /ID# 240943 Kashiwa-shi, Chiba, Japan
  • Hokkaido University Hospital /ID# 242672 Sapporo, Hokkaido, Japan
  • Kanazawa University Hospital /ID# 240948 Kanazawa, Ishikawa-ken, Japan
  • Duplicate_Okayama Medical Center /ID# 240949 Okayama, Okayama-ken, Japan
View Trial Details
Active, Not Recruiting

Study of Venetoclax in Combination With Carfilzomib and Dexamethasone in Participants With Relapsed or Refractory Multiple Myeloma (MM)

NCT02899052

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations
  • University of Alabama at Birmingham - Main /ID# 151405 Birmingham, Alabama, United States
  • University of Arkansas for Medical Sciences /ID# 151399 Little Rock, Arkansas, United States
  • Memorial Healthcare System /ID# 224862 Hollywood, Florida, United States
  • Winship Cancer Institute of Emory University /ID# 161710 Atlanta, Georgia, United States
View all 32 locations
View Trial Details
Active, Not Recruiting

Ixazomib-pomalidomide-dexamethasone as Second or Third-line Combination Treatment for Patients With Relapsed and Refractory Multiple Myeloma Previously Treated With Daratumumab, Lenalidomide and Bortezomib

NCT04790474

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations
  • Emek Medical Center Afula, Israel
  • Rambam Medical Center Haifa, Israel
  • Hadassah Ein-Kerem Medical Center Jerusalem, Israel
  • Shearei Zedek Medical Center Jerusalem, Israel
View Trial Details
Active, Not Recruiting

Isa-RVD Study in Patients With Newly Diagnosed Multiple Myeloma

NCT05123131

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Aarhus University Hospital Aarhus, Denmark
  • Beaumont Hospital Dublin, Ireland
  • Mater Misericordiae University Hospital Dublin, Ireland
  • St James's Hospital Dublin, Ireland
View Trial Details
Active, Not Recruiting

Multiple Myeloma Molecular Monitoring Study

NCT03421132

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Tom Baker Cancer Centre Calgary, Alberta, Canada
  • Cross Cancer Institute Edmonton, Alberta, Canada
  • Vancouver General Hospital Vancouver, British Columbia, Canada
  • CancerCare Manitoba Winnipeg, Manitoba, Canada
View Trial Details

Related conditions